RUBICON RESEARCH (RUBICON) Share Price Falls 2.47% Today
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
RUBICON Share Price was at Rs 1,593.85, down 2.47% in today’s trade, with market capitalisation at Rs 27,051.22 Cr. RUBICON RESEARCH moved lower from the previous close of Rs 1,634.20 after opening at Rs 1,623.70 and touching a high of Rs 1,636.70 before slipping to a low of Rs 1,591.05. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes RUBICON Share Price important to watch not just for the daily move, but also for the valuation context, healthcare sector positioning and the way RUBICON Stock News is being tracked by investors today.
RUBICON Share Price Today is also relevant because the stock sits in the Large Cap category, which places the move in a broader institutional context rather than a narrow trading one. For readers searching RUBICON Share Price Today, RUBICON Share Price Fall or RUBICON Stock News, the key question is whether the current revaluation in RUBICON Share Price is supported by its fundamentals. The latest Univest figures suggest the answer needs to be read through earnings quality, premium valuation and peer comparison rather than through a single-session headline alone.
RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,593.85 |
| Previous Close | Rs 1,634.2 |
| Today's Move | -Rs 40.35 (-2.47%) |
| Open | Rs 1,623.7 |
| High | Rs 1,636.7 |
| Low | Rs 1,591.05 |
| Market Capitalisation | Rs 27,051.22 crore |
| Market Cap Category | Large Cap |
RUBICON Share Price Today reflected a decline of Rs 40.35 from the previous close, with the stock last traded at Rs 1,593.85. The day opened at Rs 1,623.70, moved to an intraday high of Rs 1,636.70 and a low of Rs 1,591.05, showing that RUBICON Share Price remained close to the lower end of its range as the move developed. With market capitalisation of Rs 27,051.22 Cr, RUBICON RESEARCH remains a Large Cap name, so today’s decline is being read alongside a sizeable equity base rather than as a narrow small-company swing.
For those tracking RUBICON Share Price Live or RUBICON Share Price Update, the sequence matters more than the size of the single move: the stock is lower by 2.47% from the previous close, and the difference between the opening level and the day’s low shows that RUBICON Share Price did not hold the morning level through the current trade. RUBICON Share Price Today therefore becomes a useful signal for investors who want to compare current trade with company valuation and sector context. That leads directly to RUBICON Fundamental Analysis.
RUBICON RESEARCH (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,051.22 crore |
| P/E Ratio | 93.86x |
| P/B Ratio | 20.15x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.09% |
RUBICON RESEARCH (RUBICON) fundamental metrics show P/E 93.86x, P/B 20.15x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.
RUBICON RESEARCH has a market capitalisation of Rs 27,051.22 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 93.86x, P/B at 20.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.27x, median ROE of 11.48%, median ROCE of 13.17%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 93.86x |
| Benchmark Median P/E | 32.27x |
| Benchmark Average P/E | 48.67x |
| Benchmark P/E Range | 3.58x to 685.2x |
| Company P/B Ratio | 20.15x |
| Benchmark Median P/B | 2.87x |
| Benchmark Average P/B | 4.28x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.77% |
| Company Market Capitalisation | Rs 27,051.22 crore |
| Benchmark Median Market Cap | Rs 714 crore |
| Benchmark Average Market Cap | Rs 13,708.65 crore |
RUBICON RESEARCH (RUBICON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
RUBICON RESEARCH (RUBICON) has a P/E ratio of 93.86x, which is above the benchmark median of 32.27x, a difference of +190.86%. On its own, the P/E gap is a valuation reference point, not a trading call.
RUBICON RESEARCH (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.48%, a difference of +142.51%. RUBICON RESEARCH (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.17%, a difference of +121.87%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,34,279.63 | 35.9 | 5.02 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,737.12 | 84.35 | 13.97 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,129.27 | 83.05 | 20.18 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,14,239.13 | 25.31 | 4.24 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,08,808.05 | 32.28 | 3.1 | 11.83 | 16 |
RUBICON RESEARCH (RUBICON) has a P/E ratio of 93.86x compared with the displayed peer median of 35.9x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH (RUBICON) has a market capitalisation of Rs 27,051.22 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching RUBICON
- RUBICON Share Price fell 2.47% in today’s trade and stayed near the lower end of the day’s range.
- RUBICON Share Price Today is being assessed against a high P/E of 93.86 and P/B of 20.15.
- The company’s ROE of 27.84% and ROCE of 29.22% provide a strong return-profile backdrop for RUBICON Stock Analysis.
- RUBICON Market Cap of Rs 27,051.22 Cr places the stock in the Large Cap category.
- Sector comparison shows RUBICON Share Price trading at a premium to the Pharmaceuticals & Drugs benchmark.
About RUBICON RESEARCH
RUBICON RESEARCH operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business is tracked by investors as a Large Cap company with a market capitalisation of Rs 27,051.22 Cr. RUBICON Share Price matters because the company’s valuation and return ratios suggest a market that expects strong operating execution. Within the sector, RUBICON Stock News is often viewed through the lens of how its earnings base, book value and return ratios compare with other listed pharma names.
At the financial level, RUBICON Share Price is linked to EPS of Rs 17.41, book value of Rs 81.09 and a dividend yield of 0.09%. Those figures help explain why the stock attracts attention in RUBICON Fundamental Analysis discussions. The company’s placement in Healthcare also keeps it relevant when investors scan RUBICON Company News and broader market updates around pharma valuations.
Track RUBICON Share Price on Univest
Use RUBICON RESEARCH (RUBICON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track RUBICON Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and sector context. RUBICON Share Price Today can be followed alongside peer comparisons, company overview data and market insights in one place. Univest helps readers monitor RUBICON Stock News, RUBICON Share Price Fall and RUBICON Share Price Update without losing sight of the underlying fundamentals.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did RUBICON Share Price fall today?
Ans. RUBICON Share Price fell 2.47% to Rs 1,593.85 in today’s trade. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The move needs to be read with valuation and sector context.
What is RUBICON Share Price Today?
Ans. RUBICON Share Price Today stood at Rs 1,593.85, compared with the previous close of Rs 1,634.20. The stock traded between Rs 1,591.05 and Rs 1,636.70 during the day, showing a relatively tight intraday range.
Is RUBICON a Large Cap stock?
Ans. Yes, RUBICON is classified as a Large Cap company. Its market capitalisation is Rs 27,051.22 Cr, which places it well above the industry median in the latest peer universe used for comparison.
What does RUBICON Fundamental Analysis show?
Ans. RUBICON Fundamental Analysis shows a P/E of 93.86, P/B of 20.15, ROE of 27.84% and ROCE of 29.22%. EPS is Rs 17.41 and book value is Rs 81.09, indicating a premium-valued pharma name.
How does RUBICON compare with sector benchmarks?
Ans. RUBICON Share Price carries a P/E above the industry median of 32.27 and average of 48.67. Its ROE and ROCE are also above sector median and average levels, while P/B is far higher than benchmark norms.
How does RUBICON compare with peers?
Ans. RUBICON Share Price trades above peers such as Sun Pharmaceutical, Zydus Lifesciences and Cipla on valuation multiples. It also carries a stronger return profile than several peers, which keeps peer comparison central to the stock story.
What is the dividend yield on RUBICON Share Price?
Ans. RUBICON has a dividend yield of 0.09%. That is a very small yield at the current RUBICON Share Price, so the stock is being read more for earnings quality and valuation than for income.
Should investors track RUBICON Share Price now?
Ans. Investors tracking RUBICON Share Price may want to watch valuation, earnings delivery and sector comparison. The stock’s premium P/E and P/B, along with strong ROE and ROCE, make it a name that stays relevant in market updates.
